• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种人骨髓瘤细胞系,产淀粉酶的KMS-12-PE和不产淀粉酶的KMS-12-BM,是从一名患者体内建立的,它们具有相同的染色体标记,即t(11;14)(q13;q32)。

Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32).

作者信息

Ohtsuki T, Yawata Y, Wada H, Sugihara T, Mori M, Namba M

机构信息

Department of Medicine, Kawasaki Medical School, Kurashiki, Japan.

出版信息

Br J Haematol. 1989 Oct;73(2):199-204. doi: 10.1111/j.1365-2141.1989.tb00252.x.

DOI:10.1111/j.1365-2141.1989.tb00252.x
PMID:2479409
Abstract

Two human myeloma cell lines, KMS-12-PE and KMS-12-BM, were established from a 64-year-old woman with a non-producing type of multiple myeloma. The KMS-12-PE line originated from the pleural effusion and the KMS-12-BM from the bone marrow. These two lines showed the same chromosome marker, t(11:14)(q13:q32). However, their phenotypes of surface markers differed from each other. KMS-12-BM cells were positive to CD20, CD38 and PCA-1. showing the plasmacytoid (immature plasma cell) stage of B-cell differentiation, while KMS-12-PE cells were positive to CD38 and PCA-1, but not to CD20, indicating the terminal differentiated stage of B-cells. As seen in the pleural effusion of the patient. KMS-12-PE cells ectopically produced a salivary type of amylase, but KMS-12-BM cells did not. Interestingly, the chromosome abnormality of del(1)(p22----pter) near the region of 1p21, where the amylase gene was assigned, was noticed in as many as 76% of KMS-12-PE cells.

摘要

两种人骨髓瘤细胞系,KMS - 12 - PE和KMS - 12 - BM,是从一名64岁的非分泌型多发性骨髓瘤女性患者中建立的。KMS - 12 - PE细胞系源自胸腔积液,KMS - 12 - BM细胞系源自骨髓。这两种细胞系显示出相同的染色体标记,即t(11:14)(q13:q32)。然而,它们的表面标志物表型彼此不同。KMS - 12 - BM细胞对CD20、CD38和PCA - 1呈阳性,显示B细胞分化的浆细胞样(未成熟浆细胞)阶段,而KMS - 12 - PE细胞对CD38和PCA - 1呈阳性,但对CD20呈阴性,表明是B细胞的终末分化阶段。如在患者的胸腔积液中所见,KMS - 12 - PE细胞异位产生一种唾液型淀粉酶,但KMS - 12 - BM细胞不产生。有趣地是,在多达76%的KMS - 12 - PE细胞中发现了靠近淀粉酶基因所在的1p21区域的1号染色体缺失(del(1)(p22----pter))异常。

相似文献

1
Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32).两种人骨髓瘤细胞系,产淀粉酶的KMS-12-PE和不产淀粉酶的KMS-12-BM,是从一名患者体内建立的,它们具有相同的染色体标记,即t(11;14)(q13;q32)。
Br J Haematol. 1989 Oct;73(2):199-204. doi: 10.1111/j.1365-2141.1989.tb00252.x.
2
[Ectopic production of amylase by a non-producing type of multiple myeloma].[非淀粉酶产生型多发性骨髓瘤的淀粉酶异位产生]
Rinsho Ketsueki. 1990 Jul;31(7):1022-7.
3
Cellular biological differences between human myeloma cell lines KMS-12-PE and KMS-12-BM established from a single patient.从一名患者身上建立的人骨髓瘤细胞系KMS-12-PE和KMS-12-BM之间的细胞生物学差异。
Int J Hematol. 2000 Aug;72(2):216-22.
4
Establishment of CD7+ human myeloma sister cell lines, KMS-21-PE and KMS-21-BM, carrying t(11;14) and t(8;14).
Leuk Lymphoma. 2001 Aug;42(4):761-74. doi: 10.3109/10428190109099339.
5
Establishment of five human myeloma cell lines.五种人骨髓瘤细胞系的建立。
In Vitro Cell Dev Biol. 1989 Aug;25(8):723-9. doi: 10.1007/BF02623725.
6
Establishment of a new human myeloma cell line, KMS-18, having t(4;14)(p16.3;q32.3) derived from a case phenotypically transformed from Ig A-lambda to BJP-lambda, and associated with hyperammonemia.
Int J Oncol. 1998 Mar;12(3):545-52. doi: 10.3892/ijo.12.3.545.
7
Messenger RNA levels of five genes located at chromosome 11q13 in B-cell tumors with chromosome translocation t(11;14)(q13;q32).在伴有染色体易位t(11;14)(q13;q32)的B细胞肿瘤中,位于染色体11q13上的五个基因的信使核糖核酸水平
Cancer Res. 1994 Jan 15;54(2):377-9.
8
[Establishment and characterization of five human myeloma cell lines].[五种人骨髓瘤细胞系的建立与鉴定]
Hum Cell. 1989 Sep;2(3):297-303.
9
Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4;14)(q16.3;q32. 3) and FGFR3 translocation.成纤维细胞生长因子和FGF受体家族基因在人骨髓瘤细胞中的表达,包括具有t(4;14)(q16.3;q32.3)和FGFR3易位的细胞系。
Int J Oncol. 1999 Dec;15(6):1205-12. doi: 10.3892/ijo.15.6.1205.
10
Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma.
Blood. 1998 Sep 1;92(5):1743-8.

引用本文的文献

1
Replacing the phthalimide core in thalidomide with benzotriazole.将沙利度胺的邻苯二甲酰亚胺核心替换为苯并三唑。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):527-530. doi: 10.1080/14756366.2021.2024525.
2
Chromosomal translocation t(11;14) and p53 deletion induced by the CRISPR/Cas9 system in normal B cell-derived iPS cells.CRISPR/Cas9 系统诱导正常 B 细胞来源的 iPS 细胞发生染色体易位 t(11;14)和 p53 缺失。
Sci Rep. 2021 Mar 4;11(1):5216. doi: 10.1038/s41598-021-84628-5.
3
Bufalin induces DNA damage response under hypoxic condition in myeloma cells.
蟾毒灵在缺氧条件下诱导骨髓瘤细胞发生DNA损伤反应。
Oncol Lett. 2018 May;15(5):6443-6449. doi: 10.3892/ol.2018.8091. Epub 2018 Feb 21.
4
Establishment of induced pluripotent stem cells from normal B cells and inducing AID expression in their differentiation into hematopoietic progenitor cells.从正常 B 细胞诱导多能干细胞,并在其分化为造血祖细胞过程中诱导 AID 表达。
Sci Rep. 2017 May 10;7(1):1659. doi: 10.1038/s41598-017-01627-1.
5
Discovery and Optimization of Macrocyclic Quinoxaline-pyrrolo-dihydropiperidinones as Potent Pim-1/2 Kinase Inhibitors.作为强效Pim-1/2激酶抑制剂的大环喹喔啉-吡咯并-二氢哌啶酮的发现与优化
ACS Med Chem Lett. 2016 Feb 12;7(4):408-12. doi: 10.1021/acsmedchemlett.5b00403. eCollection 2016 Apr 14.
6
Lactate, a putative survival factor for myeloma cells, is incorporated by myeloma cells through monocarboxylate transporters 1.乳酸是骨髓瘤细胞的一种假定存活因子,骨髓瘤细胞通过单羧酸转运蛋白1摄取乳酸。
Exp Hematol Oncol. 2015 Apr 21;4:12. doi: 10.1186/s40164-015-0008-z. eCollection 2015.
7
Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells.紫草素在多发性骨髓瘤细胞中双重作用于蛋白酶体抑制剂和坏死性凋亡诱导剂。
Int J Oncol. 2015 Mar;46(3):963-72. doi: 10.3892/ijo.2014.2804. Epub 2014 Dec 19.
8
A case of salivary-type amylase-producing multiple myeloma presenting as mediastinal plasmacytoma and myelomatous pleural effusion.一例表现为纵隔浆细胞瘤和骨髓瘤性胸腔积液的唾液型淀粉酶分泌性多发性骨髓瘤病例。
Ann Lab Med. 2014 Nov;34(6):463-5. doi: 10.3343/alm.2014.34.6.463. Epub 2014 Oct 28.
9
Hypoxia reduces CD138 expression and induces an immature and stem cell-like transcriptional program in myeloma cells.缺氧降低骨髓瘤细胞中 CD138 的表达,并诱导其呈现幼稚和干细胞样的转录程序。
Int J Oncol. 2013 Dec;43(6):1809-16. doi: 10.3892/ijo.2013.2134. Epub 2013 Oct 10.
10
A novel selective small-molecule PI3K inhibitor is effective against human multiple myeloma in vitro and in vivo.一种新型选择性小分子 PI3K 抑制剂对人多发性骨髓瘤的体内外均有疗效。
Blood Cancer J. 2013 Sep 6;3(9):e141. doi: 10.1038/bcj.2013.37.